GLP-1 Medications and Where They Fit

GLP-1 is a hormone the gut releases in response to food. It slows how quickly the stomach empties, signals fullness to the brain, and improves how the body handles glucose. Medications in this class mimic that signal and sustain it.

A practical effect many people notice is that food noise quiets. Hunger is less insistent, meals end sooner, and the constant background negotiation with appetite gets quieter.

That is a hormonal change, not a willpower change. It is worth saying plainly, because the difference explains why these medications work when advice alone did not.

For many people they are the treatment. Started thoughtfully, titrated slowly, supported with adequate protein and monitored with laboratory follow up, they can address metabolic disease without any procedure.

For others they are part of a sequence. They may be used before a procedure to improve metabolic control, or after one to support and extend the result. The two act on the same physiology by different routes.

Protein becomes a priority. When appetite drops sharply, intake can fall below what the body needs to preserve muscle, and that is the most common avoidable problem with these medications.

Hydration matters. Nausea, constipation, and reflux symptoms are common early and often improve with slower titration.

Follow up is not optional. Dose changes, laboratory monitoring, and nutrition checks are what separate a good result from a difficult one.

Slower stomach emptying is part of how these medications work, and for some people it makes reflux worse. Nausea and regurgitation are reported often enough to be worth planning for.

If you have known reflux, that belongs in the conversation before starting. If reflux develops or worsens after starting, it is worth evaluating rather than tolerating indefinitely.

These medications slow stomach emptying, which can raise aspiration risk under anesthesia. Current multi society guidance from 2024 individualizes management rather than stopping the medication in every case. Many patients continue and follow a clear liquid diet for twenty four hours beforehand. This is coordinated directly with anesthesia.

Never stop or change a prescribed dose on your own. Share the medication, the dose, and the date of your last injection when the procedure is scheduled.

The physiology these medications suppress does not disappear while they are working. Weight regain is common after anti-obesity medication is discontinued, although the amount and timing vary by medication and individual. That is physiology, not a failure of effort. GLP-1 therapy and endoscopic or surgical treatment are increasingly combined rather than treated as alternatives, and for someone who has plateaued or discontinued, ESG can provide an anatomic complement.

That is not a reason to avoid them. It is a reason to have a plan for the long term at the start rather than at the end, whether that plan is continued medication, a procedure, or a structured transition.

Cost, supply, tolerance, and preference all end up in that conversation, and all of them are legitimate.

This page is educational information, not medical advice. What is right for you is decided in consultation, after a review of your history, your symptoms, and your testing.